Clinical Trials Directory

Trials / Completed

CompletedNCT03550131

Innovations in Dementia Empowerment and Action

Aging With Pride: Innovations in Dementia Empowerment and Action

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
322 (actual)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

The lack of efficacious research-based interventions for such vulnerable older adults with Alzheimer's disease and related dementias (AD/RD) and their caregivers (CGs) is a significant public health problem. Caregiving of sexual/gender minority older adults with AD/RD is of concern due to social stigma, marginalization, and isolation, which may be barriers to sustaining caregiving. It is necessary and timely to translate evidence-based culturally adaptable interventions for this underserved and stigmatized population. Reducing Disability in Alzheimer's Disease (RDAD) has been evaluated in a randomized controlled trial and has shown to successfully train community-dwelling CR (care receiver)-CG dyads to increase the physical activity and functioning of individuals with AD/RD and their CGs and to teach CGs techniques for managing behavioral symptoms of CRs. RDAD consequently decreases stress of CGs, delays institutionalization of CRs, and increases health related quality of life (HRQOL) of CRs and CGs. Thus, this study will evaluate the effect of the standard RDAD among lesbian, gay, bisexual, and transgender (LGBT) CRs with AD/RD and their CGs, and this study will test a personalized intervention tailored to better respond to distinct risks experienced by CGs and LGBT CRs with AD/RD, addressing unique sexual/gender minority CG risk factors (e.g., identity management, stigma-related adverse or traumatic life events, and lack of social support).

Detailed description

We will address the following aims: Aim 1. Test the translation and enhancement of intervention designed to increase physical activities of older adult care receivers (CRs) with AD/RD and their CGs. Aim 2. Evaluate the short- and long-term effect of the standard and personalized intervention on primary (physical activity and functioning; perceived stress for CGs; independence/residential status (institutionalization) for CRs) and secondary outcomes (HRQOL; depressive symptomatology; behavioral disturbances for CRs). Aim 3. Test the moderating roles of CR-CG characteristics, including type of CR-CG relationship, sex, and severity of CR AD/RD, on the treatment effect of the standard and personalized intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALInnovations in Dementia Empowerment and Action (IDEA)The IDEA intervention has the same exposure to treatment as the RDAD intervention. The behavioral component of the treatment manual is adapted to incorporate 3 risk factors that are empirically known to affect midlife and older LGBT populations.These include: 1) identity management; 2) stigma-related adverse/traumatic life events; and 3) lack of social support. All other aspects of the treatment are preserved.
BEHAVIORALReducing Disabilities in Alzheimer's Disease (RDAD)The RDAD intervention includes behavioral management training for caregiver and activities and exercise training for caregiver and care receiver.

Timeline

Start date
2018-12-05
Primary completion
2023-05-16
Completion
2023-05-16
First posted
2018-06-08
Last updated
2024-07-25
Results posted
2024-07-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03550131. Inclusion in this directory is not an endorsement.

Innovations in Dementia Empowerment and Action (NCT03550131) · Clinical Trials Directory